stockrowSmith & Nephew SNATS, Inc. (SNN) vs Zimmer Biomet Holdings, Inc. (ZBH)
- Smith & Nephew SNATS, Inc. SNN 31.14 −2.72%
- Zimmer Biomet Holdings, Inc. ZBH 105.40 −1.36%
Smith & Nephew SNATS, Inc. and Zimmer Biomet Holdings, Inc. are both Medical Devices companies. Zimmer Biomet Holdings, Inc. is the larger, with a market value of $20.4B against $13.4B — 1.5× the size. Zimmer Biomet Holdings, Inc. trades at the lower P/E: 26.9× against 38.9×. Zimmer Biomet Holdings, Inc. grew revenue faster over the last twelve months: 6.98% against 4.81%. Zimmer Biomet Holdings, Inc. has the higher net margin (8.95% vs 6.71%) and the higher return on invested capital (3.66% vs 0.00%). Both pay a dividend; Smith & Nephew SNATS, Inc. yields more (2.49% vs 0.90%). Across the 23 metrics below, Smith & Nephew SNATS, Inc. leads on 12 and Zimmer Biomet Holdings, Inc. on 11.
Valuation
Profitability
| Metric | SNN | ZBH | Medical Devices median |
|---|---|---|---|
| Gross margin | 70.52% | 69.68% | 57.76% |
| Operating margin | 0.00% | 13.55% | (15.07%) |
| Net margin | 6.71% | 8.95% | (14.45%) |
| Free cash flow margin | 0.00% | 13.02% | (3.88%) |
| Return on equity | 0.00% | 6.02% | (10.35%) |
| Return on assets | 0.00% | 3.26% | (17.26%) |
| Return on invested capital | 0.00% | 3.66% | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack